Houston D S, Vanhoutte P M
Department of Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, Minnesota.
J Pharmacol Exp Ther. 1988 Jan;244(1):1-10.
To characterize the responses of the canine coronary artery to serotonin, rings with and without endothelium were suspended in organ chambers for isometric tension recording. Serotonin evoked an endothelium-dependent relaxation of prostaglandin F2 alpha-contracted rings which was inhibited by antagonists with affinity for 5-hydroxytryptamine (5-HT)1 and 5-HT2 receptors, methiothepin and metergoline, but was not mimicked or antagonized by the 5-HT1A-selective ligand, 8-hydroxy-2-di-n-propylamino tetralin. This relaxation is not mediated by 5-HT1B receptors as it was not antagonized by cyanopindolol; similarly, lack of inhibition by ketanserin and MDL 72222 rule out contributions of 5-HT2 receptors or 5-HT3 receptors. Rings without endothelium contracted to serotonin; this contraction was not blocked by cyanopindolol and was only weakly inhibited by ketanserin, but was antagonized in an apparently competitive fashion by methiothepin and was mimicked by 8-hydroxy-2-di-n-propylamino tetralin (although at higher concentrations than would be expected for its action at a 5-HT1A receptor). At high concentrations, serotonin evoked a relaxation of endothelium-denuded rings, which was blocked by very low concentrations of methiothepin but was unaffected by ketanserin or cyanopindolol. Thus, there appear to be three different serotonergic receptors in the coronary artery. Although available agents do not allow their precise classification as yet, none of them is of the 5-HT2 type.
为了描述犬冠状动脉对5-羟色胺的反应,将有内皮和无内皮的血管环悬挂于器官浴槽中以记录等长张力。5-羟色胺引起前列腺素F2α预收缩的有内皮血管环出现内皮依赖性舒张,该舒张被对5-羟色胺(5-HT)1和5-HT2受体有亲和力的拮抗剂美噻吨和麦角苄酯抑制,但不被5-HT1A选择性配体8-羟基-2-二正丙基氨基四氢萘模拟或拮抗。该舒张不是由5-HT1B受体介导的,因为它不被氰吲哚洛尔拮抗;同样,酮色林和MDL 72222缺乏抑制作用排除了5-HT2受体或5-HT3受体的作用。无内皮的血管环对5-羟色胺收缩;该收缩不被氰吲哚洛尔阻断,仅被酮色林微弱抑制,但被美噻吨以明显竞争性方式拮抗,并被8-羟基-2-二正丙基氨基四氢萘模拟(尽管所需浓度高于其作用于5-HT1A受体时预期的浓度)。在高浓度时,5-羟色胺引起去内皮血管环舒张,该舒张被极低浓度的美噻吨阻断,但不受酮色林或氰吲哚洛尔影响。因此,冠状动脉中似乎存在三种不同的5-羟色胺能受体。尽管现有药物尚不能对它们进行精确分类,但它们都不是5-HT2型。